|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/513 | (2006.01) |
| C07D 239/54 | (2006.01) | ||
| C07D 401/06 | (2006.01) | ||
| A61P 31/06 | (2006.01) |
| (11) | Number of the document | 3432887 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17710980.8 |
| Date of filing the European patent application | 2017-03-20 | |
| (97) | Date of publication of the European application | 2019-01-30 |
| (45) | Date of publication and mention of the grant of the patent | 2020-09-02 |
| (46) | Date of publication of the claims translation | 2020-12-10 |
| (86) | Number | PCT/EP2017/056565 |
| Date | 2017-03-20 |
| (87) | Number | WO 2017/162591 |
| Date | 2017-09-28 |
| (30) | Number | Date | Country code |
| 16382124 | 2016-03-22 | EP |
| (72) |
BALLELL PAGES, Lluis, ES
BARROS AGUIRRE, David, ES
BATES, Robert H, ES
CASTRO PICHEL, Julia, ES
ESQUIVIAS PROVENCIO, Jorge, ES
PETHE, Kevin, SG
|
| (73) |
GlaxoSmithKline Intellectual Property Development Limited,
980 Great West Road, Brentford Middlesex TW8 9GS,
GB
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Prieštuberkuliozinis agentas |
| ANTITUBERCULOSIS AGENT |
| Payment date | Validity (years) | Amount | |
| 2025-02-18 | 9 | 208.00 EUR |
| 2026-03-20 |